From the source
From the source
From the source

From the source
Isomorphic Labs announces it has raised $5 Billion in Series C funding. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz (a16z) and several other new investors, with continued significant investment from Alphabet.
The round also included participation from all existing investors: Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. Isomorphic Labs is focussed on designing and developing new medicines with AI, ushering in a new era of biomedical breakthroughs.
The company is scaling its proprietary drug design engine (IsoDDE) and therapeutic candidate pipeline designed with AI to deliver the next generation of medicines for patients. Read more in the news release below. Isomorphic Labs announces $5 Billion Series C Round
isomorphiclabs.com